New York, NY, United States of America

George David Falus

USPTO Granted Patents = 5 

Average Co-Inventor Count = 1.4

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • New York, NY (US) (2012)
  • New York City, NY (US) (2013 - 2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by George David Falus in Hemostasis

Introduction

George David Falus is an accomplished inventor based in New York, NY (US), known for his significant contributions to the field of hemostatic agents. With a total of five patents to his name, he has developed innovative solutions aimed at addressing intraoperative and traumatic hemorrhage.

Latest Patents

One of his latest inventions is the Single Component Fibrin Hemostat, known as ClotGel. This product is designed for use as an adjunct or primary treatment in moderate intraoperative hemorrhage and trauma. ClotGel can be applied topically to wounds, whether on the skin during a laparotomy or in a non-invasive manner during surgical procedures. Its unique crosslinking technology generates a stable fibrin clot using a single component, fibrin II, which is essential for hemostasis. The gel consists of a mixture of lyophilized polymerized fibrin II and fibrin II monomer, which polymerizes and stabilizes upon contact with blood. The rapid formation of a strong, stable fibrin clot occurs within one minute of application.

Another notable patent is the Lyophilized Fibrin Sealant for High Volume Hemorrhage, branded as ClotBlock. This hemostatic agent is designed for moderate to severe hemorrhage and can be applied directly to wounds during laparotomy procedures or as a non-invasive sealant. ClotBlock's crosslinking technology creates a strong and safe adhesive fibrin sealant necessary for high volume hemostasis. The product ensures a stable fibrin clot is formed within one to five minutes, depending on the severity of the wound. ClotBlock is safe, biocompatible, biodegradable, and can be stored at room temperature for up to one year.

Career Highlights

Throughout his career, George David Falus has worked with various organizations, including Biomedica Management Corporation. His work has focused on developing advanced medical solutions that enhance patient outcomes during surgical procedures.

Collaborations

George has collaborated with notable professionals in the field, including his coworker Leonid Medved, who has contributed to the development of his innovative products.

Conclusion

George David Falus has made remarkable strides in the field of hemostatic agents, with his inventions providing critical solutions for managing hemorrhage in medical settings. His work continues to impact the medical

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…